Compare Pharmacokinetics, Safety, and Immunogenicity of HLX11 vs. Perjeta in Healthy Chinese Male Subjects
Clinical trial NCT04411550 · COMPLETED
Trial details
- NCT number
- NCT04411550
- Sponsor
- Shanghai Henlius Biotech
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-01
- Primary completion
- 2021-07-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.